These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15638231)

  • 21. Mutations in clotting factors and inflammatory bowel disease.
    Bernstein CN; Sargent M; Vos HL; Rosendaal FR
    Am J Gastroenterol; 2007 Feb; 102(2):338-43. PubMed ID: 17156138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammatory bowel disease and thromboembolism.
    Zezos P; Kouklakis G; Saibil F
    World J Gastroenterol; 2014 Oct; 20(38):13863-78. PubMed ID: 25320522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Haemostatic system in inflammatory bowel diseases: new players in gut inflammation.
    Scaldaferri F; Lancellotti S; Pizzoferrato M; De Cristofaro R
    World J Gastroenterol; 2011 Feb; 17(5):594-608. PubMed ID: 21350708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Family history of inflammatory bowel disease in patients with idiopathic ocular inflammation.
    Lin P; Tessler HH; Goldstein DA
    Am J Ophthalmol; 2006 Jun; 141(6):1097-104. PubMed ID: 16765679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vascular and cellular stress in inflammatory bowel disease: revisiting the role of homocysteine.
    Peyrin-Biroulet L; Rodriguez-Guéant RM; Chamaillard M; Desreumaux P; Xia B; Bronowicki JP; Bigard MA; Guéant JL
    Am J Gastroenterol; 2007 May; 102(5):1108-15. PubMed ID: 17355415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease.
    Leach ST; Yang Z; Messina I; Song C; Geczy CL; Cunningham AM; Day AS
    Scand J Gastroenterol; 2007 Nov; 42(11):1321-31. PubMed ID: 17852869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood coagulation, fibrinolytic activity and lipid profile in subclinical thyroid disease: subclinical hyperthyroidism increases plasma factor X activity.
    Erem C
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):323-9. PubMed ID: 16487444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between coagulation state and inflammatory bowel disease: current understanding and clinical implications.
    Koutroubakis IE
    Expert Rev Clin Immunol; 2015 Apr; 11(4):479-88. PubMed ID: 25719625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperhomocysteinemia and methylenetetrahydrofolate reductase 677C-->T and 1298A-->C mutations in patients with inflammatory bowel disease.
    Fernández-Miranda C; Martínez Prieto M; Casis Herce B; Sánchez Gómez F; Gómez González P; Martínez López J; Sáenz-López Pérez S; Gómez de la Cámara A
    Rev Esp Enferm Dig; 2005 Jul; 97(7):497-504. PubMed ID: 16262529
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence of endothelial dysfunction in patients with inflammatory bowel disease.
    Roifman I; Sun YC; Fedwick JP; Panaccione R; Buret AG; Liu H; Rostom A; Anderson TJ; Beck PL
    Clin Gastroenterol Hepatol; 2009 Feb; 7(2):175-82. PubMed ID: 19121648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study.
    Katsanos KH; Vermeire S; Christodoulou DK; Riis L; Wolters F; Odes S; Freitas J; Hoie O; Beltrami M; Fornaciari G; Clofent J; Bodini P; Vatn M; Nunes PB; Moum B; Munkholm P; Limonard C; Stockbrugger R; Rutgeerts P; Tsianos EV;
    Digestion; 2007; 75(2-3):113-21. PubMed ID: 17598963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammatory bowel disease and cerebrovascular arterial and venous thromboembolic events in 4 pediatric patients: a case series and review of the literature.
    Standridge S; de los Reyes E
    J Child Neurol; 2008 Jan; 23(1):59-66. PubMed ID: 18184942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The protein C pathway in inflammatory bowel disease: the missing link between inflammation and coagulation.
    Lust M; Vulcano M; Danese S
    Trends Mol Med; 2008 Jun; 14(6):237-44. PubMed ID: 18457995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Irritable bowel syndrome and inflammatory bowel disease: Is there a connection?].
    Mearin F; Perelló A; Balboa A
    Gastroenterol Hepatol; 2009 May; 32(5):364-72. PubMed ID: 19442413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Altered status of antioxidant vitamins and fatty acids in patients with inactive inflammatory bowel disease.
    Hengstermann S; Valentini L; Schaper L; Buning C; Koernicke T; Maritschnegg M; Buhner S; Tillinger W; Regano N; Guglielmi F; Winklhofer-Roob BM; Lochs H
    Clin Nutr; 2008 Aug; 27(4):571-8. PubMed ID: 18316141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inflammatory bowel disease: epidemiology, pathology and risk factors for hypercoagulability.
    Owczarek D; Cibor D; Głowacki MK; Rodacki T; Mach T
    World J Gastroenterol; 2014 Jan; 20(1):53-63. PubMed ID: 24415858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 levels in inflammatory bowel disease.
    Koutroubakis IE; Sfiridaki A; Tsiolakidou G; Coucoutsi C; Theodoropoulou A; Kouroumalis EA
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):912-6. PubMed ID: 18794606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The coagulation-decoagulation pattern in the pathogeny of thrombotic disease. 3. "Hypercoagulability" as a prior state or as a situation reactive to thrombosis.
    Sánchez Fayos J; Outeiriño J; Paniagua G; Calabuig MT
    Bull Inst Med Res Univ Madr; 1965; 18(4):159-66. PubMed ID: 5875601
    [No Abstract]   [Full Text] [Related]  

  • 40. Role of gastrointestinal eosinophils in inflammatory bowel disease and intestinal tumours.
    Wedemeyer J; Vosskuhl K
    Best Pract Res Clin Gastroenterol; 2008; 22(3):537-49. PubMed ID: 18492570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.